Narrow Therapeutic Index Drugs: Stricter Bioequivalence Requirements Explained
Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how FDA, EMA, and Health Canada regulate generics like warfarin and levothyroxine, why costs are higher, and what this means for your treatment.
View More